B. Wörmann

1.2k total citations
40 papers, 799 citations indexed

About

B. Wörmann is a scholar working on Immunology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, B. Wörmann has authored 40 papers receiving a total of 799 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 9 papers in Pulmonary and Respiratory Medicine and 9 papers in Oncology. Recurrent topics in B. Wörmann's work include Lung Cancer Treatments and Mutations (6 papers), Immunodeficiency and Autoimmune Disorders (5 papers) and Acute Lymphoblastic Leukemia research (5 papers). B. Wörmann is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Immunodeficiency and Autoimmune Disorders (5 papers) and Acute Lymphoblastic Leukemia research (5 papers). B. Wörmann collaborates with scholars based in Germany, United States and Switzerland. B. Wörmann's co-authors include Wolfgang Hiddemann, W. Hiddemann, M. Essink, Christian Buske, J. Eberth, Tucker W. LeBien, Gerhard Behre, I. Schedel, Michaela Feuring‐Buske and Karin Schreiber and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Antimicrobial Agents and Chemotherapy.

In The Last Decade

B. Wörmann

37 papers receiving 768 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Wörmann Germany 16 204 201 187 170 152 40 799
T. F. Zipf United States 21 692 3.4× 151 0.8× 287 1.5× 107 0.6× 492 3.2× 52 1.5k
Sally Weisdorf United States 16 550 2.7× 113 0.6× 153 0.8× 53 0.3× 84 0.6× 29 1.4k
Xiaoyu Lai China 20 526 2.6× 195 1.0× 271 1.4× 32 0.2× 146 1.0× 124 1.3k
Rana Ezzeddine United States 19 744 3.6× 657 3.3× 125 0.7× 45 0.3× 73 0.5× 46 1.7k
Stéphane Girault France 10 103 0.5× 40 0.2× 67 0.4× 120 0.7× 59 0.4× 23 404
Elisabetta Cosulich Italy 15 26 0.1× 129 0.6× 158 0.8× 81 0.5× 24 0.2× 24 594
Yves Rees United Kingdom 16 53 0.3× 100 0.5× 170 0.9× 50 0.3× 31 0.2× 46 1.2k
A A Moss United States 22 126 0.6× 138 0.7× 20 0.1× 65 0.4× 26 0.2× 40 1.9k
Yukihiro Tomita Japan 19 263 1.3× 47 0.2× 434 2.3× 18 0.1× 18 0.1× 108 1.4k
C. Freiburghaus Sweden 11 57 0.3× 175 0.9× 36 0.2× 268 1.6× 10 0.1× 22 1.2k

Countries citing papers authored by B. Wörmann

Since Specialization
Citations

This map shows the geographic impact of B. Wörmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Wörmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Wörmann more than expected).

Fields of papers citing papers by B. Wörmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Wörmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Wörmann. The network helps show where B. Wörmann may publish in the future.

Co-authorship network of co-authors of B. Wörmann

This figure shows the co-authorship network connecting the top 25 collaborators of B. Wörmann. A scholar is included among the top collaborators of B. Wörmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Wörmann. B. Wörmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Haase, Dagmar, et al.. (2008). Das primäre pulmonale Plasmozytom: Kasuistik eines seltenen Lungentumors. DMW - Deutsche Medizinische Wochenschrift. 123(23). 730–734. 1 indexed citations
2.
Behr, Thomas M., Stavros G. Memtsoudis, Vassilios I. Vougioukas, et al.. (1999). Radioimmunotherapy of colorectal cancer in small volume disease and in an adjuvant setting: preclinical evaluation in comparison to equitoxic chemotherapy and initial results of an ongoing phase-I/II clinical trial.. PubMed. 19(4A). 2427–32. 13 indexed citations
3.
Wulf, Gerald, Utz Reichard, B. Wörmann, & Wolfgang Hiddemann. (1998). Pneumocystis carinii pneumonia with peripheral nodular infiltrates in a patient with T-acute lymphoblastic leukemia.. Journal of Clinical Oncology. 16(10). 3476–3477. 3 indexed citations
4.
Reiser, Marcel, R. Schnell, Peter Borchmann, et al.. (1998). DIZE (Dexamethasone, Idarubicin, and Continuous Infusion of Ifosfamide and Etoposide): an Effective and Well-Tolerated New Regimen for Patients with Relapsed Lymphoma. Leukemia & lymphoma. 31(3-4). 359–366. 12 indexed citations
5.
Dalichau, H., B. Wörmann, Bernhard Hemmerlein, et al.. (1998). Induction Combination Chemotherapy with Docetaxel and Carboplatin in Advanced Non-Small-Cell Lung Cancer. The Thoracic and Cardiovascular Surgeon. 46(5). 298–302. 14 indexed citations
6.
Braess, Jan, Kristian Reich, Frank Strutz, et al.. (1997). Mucocutaneous autoimmune syndrome following fludarabine therapy for low-grade non-Hodgkin's lymphoma of B-cell type (B-NHL). Annals of Hematology. 75(5-6). 227–230. 18 indexed citations
7.
Spiekermann, Karsten, B. Wörmann, K. W. Rumpf, & Wolfgang Hiddemann. (1997). Combination chemotherapy with CHOP for recurrent thrombotic thrombocytopenic purpura. British Journal of Haematology. 97(3). 544–546. 12 indexed citations
8.
Buske, Christian, et al.. (1997). TGF-β inhibits growth and induces apoptosis in leukemic B cell precursors. Leukemia. 11(3). 386–392. 30 indexed citations
9.
Engert, Andreas, R. Schnell, Marcel Reiser, et al.. (1997). A Phase-II Study with Idarubicin, Ifosfamide and VP-16 (IIVP-16) in Patients with Refractory or Relapsed Aggressive and High Grade non-Hodgkin's Lymphoma. Leukemia & lymphoma. 24(5-6). 513–522. 13 indexed citations
10.
11.
Möller, Harald E., Peter Vermathen, Ernst J. Rummeny, et al.. (1996). In Vivo31P NMR Spectroscopy of Human Musculoskeletal Tumors as a Measure of Response to Chemotherapy. NMR in Biomedicine. 9(8). 347–358. 18 indexed citations
14.
Hiddemann, Wolfgang, B. Wörmann, A. Thiel, et al.. (1991). Treatment of advanced chronic lymphocytic leukemia by fludarabine. Annals of Hematology. 63(1). 1–4. 65 indexed citations
15.
Garritsen, Henk, et al.. (1990). Annual congress of the german and the Austrian society of hematology and oncology. Annals of Hematology. 61(2-3). 69–196. 1 indexed citations
16.
Hiddemann, Wolfgang, M. Zühlsdorf, B. Wörmann, Michael Koenigsmann, & Thomas Büchner. (1990). Changing response of clonogenic myeloid leukemia blasts to granulocyte-macrophage colony-stimulating factor (GM-CSF) during anti-leukemic therapy—A case report on the basis of a clinical phase II trial. Leukemia Research. 14(4). 347–352. 4 indexed citations
17.
Heese, J., Klaus Lieb, S. Ulbig, et al.. (1987). Spectroscopy of high spin states inBr73. Physical Review C. 36(6). 2409–2421. 22 indexed citations
19.
Wörmann, B., et al.. (1985). Association of Herpes Virus Infection of the Esophagus and Idiopathic Inflammatory Bowel Disease. Endoscopy. 17(1). 36–37. 1 indexed citations
20.
Hiddemann, Wolfgang, Th. Büchner, M. Andreeff, et al.. (1983). Vergleich der Therapieeffektivitat von zwei Induktionsprotokollen bei akuter myeloischer Leukämie (AML) mittels exakter Quantifizierung der Knochenmarkzellularität. Oncology Research and Treatment. 6(4). 179–183. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026